News & Topics

HOME > News & Topics > Research > FY 2021 > Discovering antibodies that enhance SARS-CoV-2 infection (Arase G, in Cell)

Discovering antibodies that enhance SARS-CoV-2 infection (Arase G, in Cell)

A research group led by Hisashi Arase (IFReC/RIMD/the Center for Infectious Diseases, Osaka University) discovered both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.


SARS-CoV-2 infectivity is enhanced upon antibody binding to NTD. (credit: Osaka University)


Commentary(PDF)


Article (External Link)


Contact:
Hisashi Arase

Hisashi Arase (Immunochemistry)

Tel+81-6-6879-8291
Mail arase@biken.osaka-u.ac.jp
WPI Osaka University Immunology Frontier Research Center

Archives

 
TOPに戻る